Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 7Recurrence 2Prostatic Neoplasms 2Neoplasms 2Colonic Neoplasms 2Smoking Cessation 1Pathologic Processes 1Ovarian Cancer Prevention 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neoplasms by Site 1Motor Activity 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Hairy Cell 1Intestinal Neoplasms 1Intestinal Diseases 1Inflammation 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Disease Attributes 1Digestive System Neoplasms 1Digestive System Diseases 1Colonic Diseases 1Breast Neoplasms 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Diagnostic Imaging 2Itraconazole 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Barrett Esophagus × Aspirin × Clear all
NCT02521285 2026-04-29

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

National Cancer Institute (NCI)

Phase 2 Active not recruiting
21 enrolled 35 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡